Pemigatinib is a med for dealing with cholangiocarcinoma and it works by stopping FGFR2 fusions. It keeps the FGFR signaling in check. The drug comes in 3 strengths—4.5 mg, 9 mg, and 13.5 mg pills.
For adults, the suggested dose is 13.5 mg taken every day for 2 weeks during a 3-week cycle. Each pack includes a box with 14 pills.
Reviews
There are no reviews yet.